UN Resolution on Diabetes passed!!

On Dec 20th a UN Resolution on diabetes was passed, calling upon countries worldwide to increase focus on the prevention, treatment and care for diabetes. This is a welcome opportunity to raise advocacy and awareness for the need to address the attitudes, wishes and needs of people with diabetes and those at risk world-wide.

Only six months after the ‘Unite for Diabetes’ was launched, the General Assembly of the United Nations has adopted, by a clear majority, a UN Resolution on diabetes and made World Diabetes Day (14 November) a UN-observed day.

The resolution, which was adopted at 7:59 pm on Wednesday in New York, notes that strengthening public health is critical to achieving internationally agreed development goals and that diabetes is “a chronic, debilitating and costly disease.”

“The support for this Resolution demonstrates that all nations have recognised the severity of the worldwide diabetes pandemic and have committed to urgently dealing with this. In this way, nations have acknowledged that the access to diagnosis, prevention and proper care of diabetes constitutes a human right which should no longer be violated,” says Lars Rebien Sørensen, Novo Nordisk president and CEO.

Continuing support
Novo Nordisk has played an active role in the International Diabetes Federation (IDF)-led ‘Unite for Diabetes’ campaign in support of the Resolution. Novo Nordisk and DAWN will continue to take an active leadership in implementing the UN Resolution on diabetes by:

• Establishing high-level groups of experts to facilitate new solutions for change and drive better health and quality of life outcomes for people with diabetes.
• Changing policies through partnerships with the authorities to ensure that the attitudes, wishes and needs of people with diabetes are placed at the centre of the debate.
• Engaging young people in the effort to build a better future for people with diabetes.

For more information, see:
The Unite for Diabetes website